pinocembrin has been researched along with cytochrome c-t in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hema, PS; Kumar, MA; Mohan, J; Nair, M; Santhoshkumar, TR | 1 |
| Cheng, L; Cui, Q; Miao, Y; Mir, AZ; Wang, H; Wang, L; Wang, Y; Zhao, L; Zhao, W | 1 |
| Bosco, SMD; de Oliveira, MR; Gama, CS; Peres, A | 1 |
3 other study(ies) available for pinocembrin and cytochrome c-t
| Article | Year |
|---|---|
Pinocembrin triggers Bax-dependent mitochondrial apoptosis in colon cancer cells.
Topics: Alpinia; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Blotting, Western; Breast Neoplasms; Caspase Inhibitors; Caspases; Chromatin; Colonic Neoplasms; Cytochromes c; Endothelial Cells; Fibroblasts; Flavanones; Fluorescent Antibody Technique; HCT116 Cells; Humans; Lung; Membrane Potential, Mitochondrial; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Transfection; Umbilical Cord | 2007 |
Inhibition of beta-amyloid-induced neurotoxicity by pinocembrin through Nrf2/HO-1 pathway in SH-SY5Y cells.
Topics: Amyloid beta-Peptides; Apoptosis; Cell Line, Tumor; Cytochromes c; Dose-Response Relationship, Drug; Flavanones; Gene Expression Regulation, Neoplastic; Heme Oxygenase-1; Humans; Membrane Potential, Mitochondrial; Neuroblastoma; Neuroprotective Agents; NF-E2-Related Factor 2; Peptide Fragments; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Time Factors; Transfection | 2016 |
Pinocembrin Provides Mitochondrial Protection by the Activation of the Erk1/2-Nrf2 Signaling Pathway in SH-SY5Y Neuroblastoma Cells Exposed to Paraquat.
Topics: Cell Line, Tumor; Cell Survival; Cytochromes c; Down-Regulation; Flavanones; Humans; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; Neuroblastoma; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Paraquat | 2017 |